Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;40(3):972-1001.
doi: 10.1002/med.21645. Epub 2019 Nov 12.

The aryl hydrocarbon receptor (AhR) as a breast cancer drug target

Jennifer R Baker  1 , Jennette A Sakoff  2 , Adam McCluskey  1
Affiliations
Review

The aryl hydrocarbon receptor (AhR) as a breast cancer drug target

Jennifer R Baker et al. Med Res Rev. 2020 May.

Abstract

Breast cancer is the most common cancer in women, with more than 1.7 million diagnoses worldwide per annum. Metastatic breast cancer remains incurable, and the presence of triple-negative phenotypes makes targeted treatment impossible. The aryl hydrocarbon receptor (AhR), most commonly associated with the metabolism of xenobiotic ligands, has emerged as a promising biological target for the treatment of this deadly disease. Ligands for the AhR can be classed as exogenous or endogenous and may have agonistic or antagonistic activity. It has been well reported that agonistic ligands may have potent and selective growth inhibition activity in a number of oncogenic cell lines, and one (aminoflavone) has progressed to phase I clinical trials for breast cancer sufferers. In this study, we examine the current state of the literature in this area and elucidate the promising advances that are being made in hijacking the cytosolic-to-nuclear pathway of the AhR for the possible future treatment of breast cancer.

Keywords: aryl hydrocarbon receptor; breast cancer; cancer drugs.

PubMed Disclaimer

References

REFERENCES

    1. Cancer in Australia 2019. Australian Institute of Health and Welfare, 2019: Canberra: AIHW. https://www.aihw.gov.au/reports/cancer/cancer-in-australia-2019/data. Accessed August 1, 2019.
    1. Verrill M. Metastatic disease of the breast and local recurrence. Surgery. 2016;34(1):47-51.
    1. Flatley MJ, Dodwell DJ. Adjuvant treatment for breast cancer. Surgery. 2016;34(1):43-46.
    1. Powell JB, Goode GD, Eltom SE. The aryl hydrocarbon receptor: a target for breast cancer therapy. J Cancer Ther. 2014;4(7):1177-1186.
    1. Parton M, Dowsett M, Smith I. Studies of apoptosis in breast cancer. Br Med J. 2001;322:1528-1532.

Publication types

MeSH terms

LinkOut - more resources